Actinogen Medical Limited (ASX:ACW)

Actinogen Medical Statistics

Total Valuation

ASX:ACW has a market cap or net worth of AUD 88.96 million. The enterprise value is 75.72 million.

Market Cap	88.96M
Enterprise Value	75.72M

Important Dates

The last earnings date was Thursday, August 28, 2025.

Earnings Date	Aug 28, 2025
Ex-Dividend Date	n/a

Share Statistics

ASX:ACW has 3.18 billion shares outstanding. The number of shares has increased by 37.04% in one year.

Current Share Class	3.18B
Shares Outstanding	3.18B
Shares Change (YoY)	+37.04%
Shares Change (QoQ)	+4.26%
Owned by Insiders (%)	15.45%
Owned by Institutions (%)	4.64%
Float	2.49B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	16.21
PB Ratio	4.85
P/TBV Ratio	5.37
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-5.14
EV / Sales	13.79
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-9.97

Financial Position

The company has a current ratio of 3.76, with a Debt / Equity ratio of 0.18.

Current Ratio	3.76
Quick Ratio	3.74
Debt / Equity	0.18
Debt / EBITDA	n/a
Debt / FCF	-0.43
Interest Coverage	-314.06

Financial Efficiency

Return on equity (ROE) is -77.47% and return on invested capital (ROIC) is -46.12%.

Return on Equity (ROE)	-77.47%
Return on Assets (ROA)	-41.91%
Return on Invested Capital (ROIC)	-46.12%
Return on Capital Employed (ROCE)	-82.89%
Revenue Per Employee	914,933
Profits Per Employee	-2.46M
Employee Count	6
Asset Turnover	0.24
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -24.32% in the last 52 weeks. The beta is 1.06, so ASX:ACW's price volatility has been similar to the market average.

Beta (5Y)	1.06
52-Week Price Change	-24.32%
50-Day Moving Average	0.03
200-Day Moving Average	0.03
Relative Strength Index (RSI)	53.11
Average Volume (20 Days)	3,170,334

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:ACW had revenue of AUD 5.49 million and -14.73 million in losses. Loss per share was -0.00.

Revenue	5.49M
Gross Profit	5.49M
Operating Income	-15.35M
Pretax Income	-14.73M
Net Income	-14.73M
EBITDA	-15.01M
EBIT	-15.35M
Loss Per Share	-0.00

Balance Sheet

The company has 16.50 million in cash and 3.26 million in debt, giving a net cash position of 13.24 million or 0.00 per share.

Cash & Cash Equivalents	16.50M
Total Debt	3.26M
Net Cash	13.24M
Net Cash Per Share	0.00
Equity (Book Value)	18.34M
Book Value Per Share	0.01
Working Capital	16.47M

Cash Flow

In the last 12 months, operating cash flow was -7.56 million and capital expenditures -38,021, giving a free cash flow of -7.59 million.

Operating Cash Flow	-7.56M
Capital Expenditures	-38,021
Free Cash Flow	-7.59M
FCF Per Share	-0.00

Margins

Gross margin is 100.00%, with operating and profit margins of -279.70% and -268.37%.

Gross Margin	100.00%
Operating Margin	-279.70%
Pretax Margin	-268.37%
Profit Margin	-268.37%
EBITDA Margin	-273.48%
EBIT Margin	-279.70%
FCF Margin	n/a

Dividends & Yields

ASX:ACW does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-37.04%
Shareholder Yield	n/a
Earnings Yield	-16.56%
FCF Yield	-8.54%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on December 3, 2013. It was a reverse split with a ratio of 0.5.

Last Split Date	Dec 3, 2013
Split Type	Reverse
Split Ratio	0.5

Scores

ASX:ACW has an Altman Z-Score of 3.03 and a Piotroski F-Score of 1.

Altman Z-Score	3.03
Piotroski F-Score	1